These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 4563045)

  • 1. 1,3-bis(2-chloroethyl)-1-nitrosourea (bcnu) and other nitrosoureas in cancer treatment: a review.
    Carter SK; Schabel FM; Broder LE; Johnston TP
    Adv Cancer Res; 1972; 16():273-332. PubMed ID: 4563045
    [No Abstract]   [Full Text] [Related]  

  • 2. Formulation of three nitrosoureas for intravenous use.
    Davignon JP; Yang KW; Wood HB; Cradock JC
    Cancer Chemother Rep 3; 1973 May; 4(3):7-11. PubMed ID: 4201309
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical comparison of the nitrosoureas.
    Wasserman TH; Slavik M; Carter SK
    Cancer; 1975 Oct; 36(4):1258-68. PubMed ID: 1100221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Letter: Antitumor activities of 3-(methyl-alpha-D-glucopyranos-2-yl)-1-(2-chloroethyl)-1-nitrosourea.
    Iwasaki M; Okawa H; Ninomiya K; Sekine J; Nagamatsu Y
    Gan; 1975 Jun; 66(3):347-8. PubMed ID: 1181236
    [No Abstract]   [Full Text] [Related]  

  • 5. Antitumor activities of 3-(methyl-alpha-D-glucopyranos-6-YL)-1-(2-chloroethyl)-1-nitrosourea.
    Iwasaki M; Sekido S; Ninomiya K; Sekine J; Ueno S
    Gan; 1976 Feb; 67(1):137-9. PubMed ID: 1269854
    [No Abstract]   [Full Text] [Related]  

  • 6. Biologic activity of MCNU: a new antitumor agent.
    Sekido S; Ninomiya K; Iwasaki M
    Cancer Treat Rep; 1979 Jun; 63(6):961-70. PubMed ID: 466655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experimental and clinical studies of the antitumor activity of 1-methyl-1-nitrosourea (NSC-23909).
    Emanuel NM; Vermel EM; Ostrovskaya LA; Korman NP
    Cancer Chemother Rep; 1974; 58(2):135-48. PubMed ID: 4830495
    [No Abstract]   [Full Text] [Related]  

  • 8. In vivo chemosensitization by misonidazole in sensitive and resistant tumor lines.
    Mulcahy RT; Siemann DW
    Cancer Res; 1983 Oct; 43(10):4709-13. PubMed ID: 6883329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antitumor activity and toxicity of methyl 6-[3-(2-chloroethyl)- 3-nitrosoureido]-6-deoxy-alpha-D-glucopyranoside in experimental animals.
    Fujimoto S; Tashiro T; Ogawa M
    Gan; 1984 Oct; 75(10):937-46. PubMed ID: 6510639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Success and failure in the treatment of solid tumors. 3. "Cure" of metastatic Lewis lung carcinoma with methyl-CCNU (NSC-95442) and surgery-chemotherapy.
    Mayo JG; Laster WR; Andrews CM; Schabel FM
    Cancer Chemother Rep; 1972 Apr; 56(2):183-95. PubMed ID: 5043226
    [No Abstract]   [Full Text] [Related]  

  • 11. Inhibition of solid tumors by nitrosoureas. 1. Lewis lung carcinoma.
    Montgomery JA; McCaleb GS; Johnston TP; Mayo JG; Laster WR
    J Med Chem; 1977 Feb; 20(2):291-5. PubMed ID: 836501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antitumor activity of new nitrosoureas on Yoshida sarcoma ascites cells implanted into the colon wall of rats.
    Habs M; Reinbold H; Eisenbrand G; Bhide S; Goga-Ionescu S; Schmähl D
    J Cancer Res Clin Oncol; 1981; 101(3):285-302. PubMed ID: 7309781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nitrosoureas: a review of experimental antitumor activity.
    Schabel FM
    Cancer Treat Rep; 1976 Jun; 60(6):665-98. PubMed ID: 782694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of 1-(2-chloroethyl)-3-isobutyl-3-(beta-maltosyl)-1-nitrosourea on experimental tumors.
    Akaike Y; Arai Y; Taguchi H; Satoh H
    Gan; 1982 Jun; 73(3):480-7. PubMed ID: 7129012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alterations induced by 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) in deoxyribonucleic acid synthesis in normal and tumorous tissues. Implications for optimal chemotherapy.
    Rosenoff SH; Bostick F; Young RC
    Biochem Pharmacol; 1974 Nov; 23(22):3097-106. PubMed ID: 4441409
    [No Abstract]   [Full Text] [Related]  

  • 16. Antitumor action of N-(2-chloroethyl)-N-nitrosocarbamoyl derivatives of biologically active polypeptide hormone fragments.
    Jeney A; Kopper L; Nagy P; Lapis K; Süli-Vargha H; Medzihradszky K
    Cancer Chemother Pharmacol; 1986; 16(2):129-32. PubMed ID: 3948298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic potentiation of nitrosoureas using chlorpromazine and caffeine in the treatment of murine tumors.
    Rose WC; Trader MW; Dykes DJ; Laster WR; Schabel FM
    Cancer Treat Rep; 1978 Dec; 62(12):2085-93. PubMed ID: 751716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Some new congeners of the anticancer agent 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU). Synthesis of bifunctional analogs and water soluble derivatives and preliminary evaluation of their chemotherapeutic potential.
    Eisenbrand G; Fiebig HH; Zeller WJ
    Z Krebsforsch Klin Onkol Cancer Res Clin Oncol; 1976 Aug; 86(3):279-86. PubMed ID: 136102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An analysis of 1-(2-chloroethyl)-1-nitrosourea activity at the cellular level.
    Weinkam RJ; Dolan ME
    J Med Chem; 1983 Nov; 26(11):1656-9. PubMed ID: 6226795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapy of advanced gastrointestinal cancer with the nitrosoureas.
    Moertel CG
    Cancer Chemother Rep 3; 1973 May; 4(3):27-34. PubMed ID: 4748872
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.